A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexandra M Stevens
Pediatric Early Phase Clinical Trial Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
Girish DhallRecruiting - Children'S Hospital of Orange County
Orange, California, United States
Josephine H. HaduongRecruiting - Ucsf Medical Center-Mission Bay
San Francisco, California, United States
Kieuhoa T. VoRecruiting - Children'S Hospital Colorado
Aurora, Colorado, United States
Margaret E. MacyRecruiting - Children'S National Medical Center
Washington D.C., District of Columbia, United States
AeRang KimRecruiting - Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
Jason R. FangusaroRecruiting - Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
Sara Zarnegar-LumleyRecruiting - Riley Hospital for Children
Indianapolis, Indiana, United States
Brian D. WeissRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Jonathan PaolinoRecruiting - C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
Rajen ModyRecruiting - University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
Robin L. WilliamsRecruiting - Washington University School of Medicine
St Louis, Missouri, United States
Shalini ShenoyRecruiting - Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
Nobuko HijiyaRecruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Joseph G. PresseyRecruiting - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Sarah K. TasianRecruiting - Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
Andrew BukowinskiRecruiting - Saint Jude Children'S Research Hospital
Memphis, Tennessee, United States
Matthew ReesRecruiting - Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
Alexandra M. StevensRecruiting - Seattle Children'S Hospital
Seattle, Washington, United States
Katherine G. TarlockRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Feb 2025
- Primary completion
- 31 Mar 2028
- Completion
- 31 Mar 2028
- Last update posted
- 20 Apr 2026
- Registered enrollment
- 36
- Registry id
- NCT06247787
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.